Nymox Pharmaceutical Corporation Stock News

Nymox Pharmaceutical (NASDAQ: NYMX ) stock is falling on Thursday after the company told investors its shares will be delisted. Shares of NYMX stock will no longer trade on the Nasdaq Exchange when ma

IRVINE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today that it has received a Refusal to File (“RTF”) letter from FDA on Friday May 20th a

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) has received a Refusal to File (RTF) letter from FDA regarding its marketing application for Fexapotide Triflutate. Nymox's position is that clarific

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the co

IRVINE, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has closed its $6.4 million financing announced

IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced it has entered into definitive agreements with institutional and accredited investo

Nymox Pharmaceutical <> submitted a new drug application ((NDA)) to the FDA for Fexapotide Triflutate to treat men with benign prostatic hyperplasia ((BPH))

IRVINE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce today that it has submitted the Company’s New Drug App

Gainers Inspirato Incorporated (NASDAQ: ISPO ) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI ) jumped 45.4% to settle at $0.5979 on Friday. EF Hutton recently initiated coverage on the stock with a Buy rating and a $2 price target. CarGurus, Inc. (NASDAQ: CARG ) shares gained 44% to close at $46.44 after the company reported better-than-expected Q4 results. Farfetch Limited (NYSE: FTCH ) climbed 39.4% to close at $20.92 after the company reported better-than-expected Q4 EPS results. TD Holdings, Inc. (NASDAQ: GLG ) gained 38.9% to settle at $0.25 amid overall market strength as investors react to the ongoing Russia-Ukraine conflict. KAR Auction Services, Inc. (NYSE: KAR ) shares climbed 38.4% to close at $18.94 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral. Imperial Petroleum Inc. (NASDAQ: IMPP ) gained 33.8% to close at $2.10. Universal Security Instruments, Inc. (NYSE: UUU ) climbed 32.9% to close at $3.96 after the company reported a joint merger deal with Infinite Reality.

Nymox Pharmaceutical Corp (NYMX) shares closed today at 1.5% above its 52 week low of $0.94, giving the company a market cap of $80M. The stock is currently down 61.5% year-to-date, down 62.3% over the past 12 months, and down 64.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%. Trading Activity Trading volume this week was 81.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -270.9% The company's stock price performance over the past 12 months lags the peer average by -268.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Nymox Pharmaceutical Corp (NYMX) shares closed 4.6% lower than its previous 52 week low, giving the company a market cap of $85M. The stock is currently down 59.3% year-to-date, down 60.7% over the past 12 months, and down 63.9% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 30.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -265.7% The company's stock price performance over the past 12 months lags the peer average by -263.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

HASBROUCK HEIGHTS, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it has completed all the Company’s requi

HASBROUCK HEIGHTS, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the Company) is pleased to announce that it has completed all the Companys required tasks in preparation for its planned upcoming regulatory submission for Fexapotide Triflutate for the treatment of BPH.

State Street Corp cut its position in Nymox Pharmaceutical Co. (NASDAQ:NYMX) by 95.3% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 30,494 shares of the biopharmaceutical companys stock after selling 624,899 shares during the period. State Street Corps holdings in Nymox Pharmaceutical were worth [] The post State Street Corp Has $48,000 Position in Nymox Pharmaceutical Co. (NASDAQ:NYMX) appeared first on ETF Daily News .

Nymox Pharmaceutical (NASDAQ: NYMX) is one of 38 public companies in the Diagnostic substances industry, but how does it weigh in compared to its competitors? We will compare Nymox Pharmaceutical to related companies based on the strength of its valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and risk. Analyst Recommendations This is a summary []